Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-23 |
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-22 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-20 |
mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-20 |
mRNA | HNRNPD | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-20 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-20 |
mRNA | CDCA7 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-19 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-19 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-19 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-19 |